- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.64 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- 4 x 9G4: 1-{4-[(acetylamino)methyl]phenyl}-4-(4-chlorophenoxy)-6-oxo-1,6-dihydropyridazine-3-carboxamide(Non-covalent)
9G4.2: 15 residues within 4Å:- Chain A: G.96, F.97, M.98, M.103, F.149, D.150, M.155, Y.158, M.161, A.191, G.192, P.193, I.194, W.222
- Ligands: NAD.1
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:F.149, A:F.149, A:W.222
- Hydrogen bonds: A:M.98, A:Y.158, A:I.194, A:I.194
- pi-Stacking: A:F.149, A:Y.158
- Halogen bonds: A:D.150
9G4.5: 15 residues within 4Å:- Chain B: G.96, F.97, M.98, M.103, F.149, D.150, M.155, Y.158, M.161, A.191, G.192, P.193, I.194, W.222
- Ligands: NAD.4
10 PLIP interactions:10 interactions with chain B- Hydrophobic interactions: B:F.149, B:F.149, B:P.193, B:W.222
- Hydrogen bonds: B:M.98, B:I.194, B:I.194
- pi-Stacking: B:F.149, B:Y.158
- Halogen bonds: B:D.150
9G4.7: 16 residues within 4Å:- Chain C: G.96, F.97, M.98, M.103, F.149, D.150, M.155, Y.158, M.161, A.191, G.192, P.193, I.194, L.218, W.222
- Ligands: NAD.6
12 PLIP interactions:12 interactions with chain C- Hydrophobic interactions: C:F.97, C:F.149, C:F.149, C:P.193, C:L.218, C:W.222
- Hydrogen bonds: C:M.98, C:I.194, C:I.194
- pi-Stacking: C:F.149, C:Y.158
- Halogen bonds: C:D.150
9G4.9: 15 residues within 4Å:- Chain D: G.96, F.97, M.98, M.103, F.149, D.150, M.155, Y.158, M.161, A.191, G.192, P.193, I.194, W.222
- Ligands: NAD.8
10 PLIP interactions:10 interactions with chain D- Hydrophobic interactions: D:F.149, D:F.149, D:P.193, D:W.222
- Hydrogen bonds: D:M.98, D:Y.158, D:I.194
- pi-Stacking: D:F.149, D:Y.158
- Halogen bonds: D:D.150
- 2 x MG: MAGNESIUM ION(Non-covalent)
MG.3: 3 residues within 4Å:- Chain A: D.223, Q.224, A.226
5 PLIP interactions:3 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:D.223, A:Q.224, A:A.226, H2O.8, H2O.8
MG.10: 3 residues within 4Å:- Chain D: D.223, Q.224, A.226
5 PLIP interactions:3 interactions with chain D, 2 Ligand-Water interactions- Metal complexes: D:D.223, D:Q.224, D:A.226, H2O.33, H2O.33
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lange, S., Pyridazinones: A Novel Scaffold with Excellent Physicochemical Properties and Safety Profile for a Clinically Validated Target of Mycobacterium Tuberculosis. To be Published
- Release Date
- 2015-05-20
- Peptides
- ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.64 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- 4 x 9G4: 1-{4-[(acetylamino)methyl]phenyl}-4-(4-chlorophenoxy)-6-oxo-1,6-dihydropyridazine-3-carboxamide(Non-covalent)
- 2 x MG: MAGNESIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lange, S., Pyridazinones: A Novel Scaffold with Excellent Physicochemical Properties and Safety Profile for a Clinically Validated Target of Mycobacterium Tuberculosis. To be Published
- Release Date
- 2015-05-20
- Peptides
- ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D